Evofem Biosciences, Inc. (EVFM)
OTCMKTS
· Delayed Price · Currency is USD
0.0096
+0.0006 (6.67%)
Dec 26, 2024, 12:16 PM EST
Evofem Biosciences Employees
As of December 31, 2023, Evofem Biosciences had 38 total employees, including 37 full-time and 1 part-time employees. The number of employees increased by 1 or 2.70% compared to the previous year.
Employees
38
Change (1Y)
1
Growth (1Y)
2.70%
Revenue / Employee
$449,947
Profits / Employee
-$290,000
Market Cap
1.03M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sandoz Group AG | 22,633 |
Telix Pharmaceuticals Limited | 234 |
Elekta AB (publ) | 4,718 |
Ryman Healthcare Limited | 7,700 |
Verano Holdings Corp. | 3,900 |
Vireo Growth Inc. | 490 |
Medexus Pharmaceuticals Inc. | 82 |
Evofem Biosciences News
- 5 weeks ago - Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 - PRNewsWire
- 7 weeks ago - Evofem Secures Investor Support for Proposed Merger through Voting Agreements - PRNewsWire
- 4 months ago - Evofem Biosciences Addresses the Impact of GLP-1 Medications on Oral Contraceptive Absorption and Introduces Phexxi as a Non-Oral Solution - PRNewsWire
- 4 months ago - Evofem Biosciences GAAP EPS of $0.00, revenue of $4.16M - Seeking Alpha
- 4 months ago - Evofem Biosciences Announces Financial Results for the Second Quarter of 2024 - PRNewsWire
- 5 months ago - Evofem Biosciences to Present at the OTCQB Venture Virtual Investor Conference on August 1st - GlobeNewsWire
- 5 months ago - Evofem Signs Phexxi® License Agreement for Middle East with Pharma 1 - PRNewsWire
- 5 months ago - Lupin Divests U.S. Commercial Women's Health Specialty Business to Evofem, including SOLOSEC - PRNewsWire